<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2023-352</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-7781</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРЕ- И ПОСТМЕНОПАУЗА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRE- AND POSTMENOPAUSE</subject></subj-group></article-categories><title-group><article-title>Соединения природного происхождения в купировании симптомов и снижении рисков перименопаузального периода</article-title><trans-title-group xml:lang="en"><trans-title>Naturally occurring compounds in relieving symptoms and reducing perimenopausal risks</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6589-7654</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ших</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shikh</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ших Евгения Валерьевна – доктор медицинских наук, профессор, заведующая кафедрой клинической фармакологии и пропедевтики внутренних болезней.</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Evgenia V. Shikh - Dr. Sci. (Med.), Professor, Head of the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University).</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">shikh_e_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9817-9886</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Махова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makhova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Махова Анна Александровна - доктор медицинских наук, доцент кафедры клинической фармакологии и пропедевтики внутренних болезней.</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Anna A. Makhova - Dr. Sci. (Med.), Associate Professor of the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University).</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">makhova_a_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)<country>Россия</country></aff><aff xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2023</year></pub-date><volume>0</volume><issue>15</issue><fpage>94</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ших Е.В., Махова А.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Ших Е.В., Махова А.А.</copyright-holder><copyright-holder xml:lang="en">Shikh E.V., Makhova A.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7781">https://www.med-sovet.pro/jour/article/view/7781</self-uri><abstract><p>Наиболее существенно на здоровье женщины в постменопаузе влияют метаболические нарушения, которые носят прогрессирующий характер. Остеопороз и сердечно-сосудистые заболевания представляют собой наиболее важные долгосрочные последствия и серьезно влияют на качество жизни женщин в период менопаузы. Частой причиной обращения к врачу являются приливы – внезапное чувство жара или жжения, которое начинается в области лица, шеи, верхней части груди или спине. Иногда приливы сопровождаются покраснением кожи, появлением пятен или учащенным сердцебиением. В ряде случаев наблюдается локальное повышение температуры тела. Вышеперечисленные симптомы являются результатом нарушения функционирования термочувствительных нейронов, расположенных в гипоталамической области. Золотым стандартом фармакотерапии различных симптомов менопаузы является менопаузальная гормональная терапия. Однако наличие разнообразных абсолютных и относительных противопоказаний, а также отказ пациенток от лечения в основном в связи с гормонофобией привели к тому, что менее 30% женщин в менопаузе принимают заместительную гормональную терапию и только 15% продолжают ее в течение длительного периода. Пациентки часто настаивают на естественном подходе к купированию симптомов и хотят получить научно обоснованную информацию о различных вариантах гормонального и негормонального лечения. Обеспокоенность по поводу потенциальных побочных эффектов заместительной гормональной терапии привела к повышенному интересу к использованию фитоэстрогенов для купирования симптомов менопаузы. Рационально составленная комбинация фитоэстрогенов с микронутриентами представляет собой хорошо переносимую альтернативу, которую практически без ограничений можно применять для поддержания здоровья женщин в перименопаузе.</p></abstract><trans-abstract xml:lang="en"><p>Metabolic disorders that are progressive in nature most significantly influence the health of postmenopausal women. Osteoporosis and cardiovascular diseases are the most important long-term consequences and seriously affect the menopausal women’s quality of life. Hot flashes, a sudden feeling of heat or burning that begins in the face, neck, upper chest or back regions, is a common reason to see a doctor. Sometimes, hot flashes are accompanied by redness of the skin, red blotches, or rapid heartbeat. In some cases, rises in local skin temperature are observed. The above symptoms are the result of impaired functioning of thermosensitive neurons in the hypothalamic region. Menopausal hormone therapy is the gold standard for pharmacotherapy of various menopausal symptoms. However, it has different absolute and relative contraindications, as well as patients’ refusal of treatment mainly due to hormone phobia, that have resulted in a situation where 30% of menopausal women take hormone replacement therapy and only 15% continue to take it for a long period. Patients often insist on a natural approach to symptom relief and need evidence-based information about different hormonal and non-hormonal treatment options. Concerns about potential side effects of the hormone replacement therapy resulted in increased interest rates for phytoestrogens to manage menopausal symptoms. A rational fixed dose combination of phytoestrogens and micronutrients is a well-tolerated alternative preparation to support the health of perimenopausal women, which can be used with virtually no restrictions.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>перименопауза</kwd><kwd>фитоэстрогены</kwd><kwd>изофлавоны сои</kwd><kwd>флаволигнаны</kwd><kwd>шалфей</kwd><kwd>микронутриенты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>perimenopause</kwd><kwd>phytoestrogens</kwd><kwd>soya isoflavones</kwd><kwd>flavolignans</kwd><kwd>sage</kwd><kwd>micronutrients</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001;76(5):874–878. https://doi.org/10.1016/s0015-0282(01)02909-0.</mixed-citation><mixed-citation xml:lang="en">Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001;76(5):874–878. https://doi.org/10.1016/s0015-0282(01)02909-0.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Li RL, Shen XL, Xu F, Shui XJ, Chen YM, Wang WH, Zheng JY. Evaluation of ovarian function using three dimensional ultrasound in perimenopausal women. Gynecol Endocrinol. 2019;35(12):1059–1062. https://doi.org/10.1080/09513590.2019.1625879.</mixed-citation><mixed-citation xml:lang="en">Li RL, Shen XL, Xu F, Shui XJ, Chen YM, Wang WH, Zheng JY. Evaluation of ovarian function using three dimensional ultrasound in perimenopausal women. Gynecol Endocrinol. 2019;35(12):1059–1062. https://doi.org/10.1080/09513590.2019.1625879.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ших ЕВ, Махова АА. Протективные эффекты омега-3 полиненасыщенных жирных кислот в женском здоровье. Вопросы гинекологии, акушерства и перинатологии. 2020;19(2):104–111. https://doi.org/10.20953/1726-1678-2020-2-104-111.</mixed-citation><mixed-citation xml:lang="en">Shikh EV, Makhova AA. Protective effects of omega-3 polyunsaturated fatty acids in female health. Gynecology, Obstetrics and Perinatology. 2020;19(2):104–111. (In Russ.) https://doi.org/10.20953/1726-1678-2020-2-104-111.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">De Franciscis P, Colacurci N, Riemma G, Conte A, Pittana E, Guida M, Schiattarella A. A Nutraceutical Approach to Menopausal Complaints. Medicina (Kaunas). 2019;55(9):544. https://doi.org/10.3390/medicina55090544.</mixed-citation><mixed-citation xml:lang="en">De Franciscis P, Colacurci N, Riemma G, Conte A, Pittana E, Guida M, Schiattarella A. A Nutraceutical Approach to Menopausal Complaints. Medicina (Kaunas). 2019;55(9):544. https://doi.org/10.3390/medicina55090544.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nicoletti M. Nutraceuticals and botanicals: overview and perspectives. Int J Food Sci Nutr. 2012;63(Suppl. 1):2–6. https://doi.org/10.3109/09637486.2011.628012.</mixed-citation><mixed-citation xml:lang="en">Nicoletti M. Nutraceuticals and botanicals: overview and perspectives. Int J Food Sci Nutr. 2012;63(Suppl. 1):2–6. https://doi.org/10.3109/09637486.2011.628012.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Santini A, Cammarata SM, Capone G, Ianaro A, Tenore GC, Pani L, Novellino E. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmacol. 2018;84(4):659–672. https://doi.org/10.1111/bcp.13496.</mixed-citation><mixed-citation xml:lang="en">Santini A, Cammarata SM, Capone G, Ianaro A, Tenore GC, Pani L, Novellino E. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmacol. 2018;84(4):659–672. https://doi.org/10.1111/bcp.13496.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mosconi P, Donati S, Colombo C, Mele A, Liberati A, Satolli R. Informing women about hormone replacement therapy: the consensus conference statement. BMC Womens Health. 2009;9:14. https://doi.org/10.1186/1472-6874-9-14.</mixed-citation><mixed-citation xml:lang="en">Mosconi P, Donati S, Colombo C, Mele A, Liberati A, Satolli R. Informing women about hormone replacement therapy: the consensus conference statement. BMC Womens Health. 2009;9:14. https://doi.org/10.1186/1472-6874-9-14.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Laganà AS, Vitale SG, Stojanovska L, Lambrinoudaki I, Apostolopoulos V, Chiofalo B et al. Preliminary results of a single-arm pilot study to assess the safety and efficacy of visnadine, prenylflavonoids and bovine colostrum in postmenopausal sexually active women affected by vulvovaginal atrophy. Maturitas. 2018;109:78–80. https://doi.org/10.1016/j.maturitas.2017.12.015.</mixed-citation><mixed-citation xml:lang="en">Laganà AS, Vitale SG, Stojanovska L, Lambrinoudaki I, Apostolopoulos V, Chiofalo B et al. Preliminary results of a single-arm pilot study to assess the safety and efficacy of visnadine, prenylflavonoids and bovine colostrum in postmenopausal sexually active women affected by vulvovaginal atrophy. Maturitas. 2018;109:78–80. https://doi.org/10.1016/j.maturitas.2017.12.015.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ших ЕВ, Махова АА, Ших НВ, Марин ТВ, Жукова ОВ. Выбор фитоэстрогенов и конструирование рациональных комбинаций с микронутриентами у пациенток в перименопаузе. Вопросы гинекологии, акушерства и перинатологии. 2023;22(1):83–90. https://doi.org/10.20953/1726-1678-2023-1-83-90.</mixed-citation><mixed-citation xml:lang="en">Shikh EV, Makhova AA, Shikh NV, Marin TV, Zhukova OV. Selection of phytoestrogens and development of rational combinations with micronutrients in perimenopausal patients. Gynecology, Obstetrics and Perinatology. 2023;22(1): 83–90. (In Russ.) https://doi.org/10.20953/1726-1678-2023-1-83-90.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002;77(11):1207–1218. https://doi.org/10.4065/77.11.1207.</mixed-citation><mixed-citation xml:lang="en">Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002;77(11):1207–1218. https://doi.org/10.4065/77.11.1207.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Булаев ВМ, Ших ЕВ, Сычев ДА. Безопасность и эффективность лекарственных растений. 2-е изд. М.: Практическая медицина; 2013. 272 с.</mixed-citation><mixed-citation xml:lang="en">Булаев ВМ, Ших ЕВ, Сычев ДА. Безопасность и эффективность лекарственных растений. 2-е изд. М.: Практическая медицина; 2013. 272 с.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sadeghi AH, Bakhshil M, Behboodi MZ, Goodarzi S, Haghani H. Effect of sage extract on hot flashes in postmenopausal women. Comp Med J Nurs Mid. 2013;2(4):324–335. (In Persian)</mixed-citation><mixed-citation xml:lang="en">Sadeghi AH, Bakhshil M, Behboodi MZ, Goodarzi S, Haghani H. Effect of sage extract on hot flashes in postmenopausal women. Comp Med J Nurs Mid. 2013;2(4):324–335. (In Persian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Moradi M, Ghavami V, Niazi A, Seraj Shirvan F, Rasa S. The Effect of Salvia Officinalis on Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis. Int J Community Based Nurs Midwifery. 2023;11(3):169–178. https://doi.org/10.30476/IJCBNM.2023.97639.2198.</mixed-citation><mixed-citation xml:lang="en">Moradi M, Ghavami V, Niazi A, Seraj Shirvan F, Rasa S. The Effect of Salvia Officinalis on Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis. Int J Community Based Nurs Midwifery. 2023;11(3):169–178. https://doi.org/10.30476/IJCBNM.2023.97639.2198.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas AJ, Ismail R, Taylor-Swanson L, Cray L, Schnall JG, Mitchell ES, Woods NF. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas. 2014;78(4):263–276. https://doi.org/10.1016/j.maturitas.2014.05.007.</mixed-citation><mixed-citation xml:lang="en">Thomas AJ, Ismail R, Taylor-Swanson L, Cray L, Schnall JG, Mitchell ES, Woods NF. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas. 2014;78(4):263–276. https://doi.org/10.1016/j.maturitas.2014.05.007.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 1997;26(1):63–70. https://doi.org/10.3109/10715769709097785.</mixed-citation><mixed-citation xml:lang="en">Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 1997;26(1):63–70. https://doi.org/10.3109/10715769709097785.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013;(12):CD001395. https://doi.org/10.1002/14651858.CD001395.pub4.</mixed-citation><mixed-citation xml:lang="en">Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013;(12):CD001395. https://doi.org/10.1002/14651858.CD001395.pub4.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts H, Lethaby A. Phytoestrogens for menopausal vasomotor symptoms: a Cochrane review summary. Maturitas. 2014;78(2):79–81. https://doi.org/10.1016/j.maturitas.2014.04.004.</mixed-citation><mixed-citation xml:lang="en">Roberts H, Lethaby A. Phytoestrogens for menopausal vasomotor symptoms: a Cochrane review summary. Maturitas. 2014;78(2):79–81. https://doi.org/10.1016/j.maturitas.2014.04.004.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012;19(7):776–790. https://doi.org/10.1097/gme.0b013e3182410159.</mixed-citation><mixed-citation xml:lang="en">Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012;19(7):776–790. https://doi.org/10.1097/gme.0b013e3182410159.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause. 2006;13(5):831–839. https://doi.org/10.1097/01.gme.0000227330.49081.9e.</mixed-citation><mixed-citation xml:lang="en">Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause. 2006;13(5):831–839. https://doi.org/10.1097/01.gme.0000227330.49081.9e.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li L, Xu L, Wu J, Dong L, Zhao S, Zheng Q. Comparative efficacy of nonhormonal drugs on menopausal hot flashes. Eur J Clin Pharmacol. 2016;72(9): 1051–1058. https://doi.org/10.1007/s00228-016-2090-5.</mixed-citation><mixed-citation xml:lang="en">Li L, Xu L, Wu J, Dong L, Zhao S, Zheng Q. Comparative efficacy of nonhormonal drugs on menopausal hot flashes. Eur J Clin Pharmacol. 2016;72(9): 1051–1058. https://doi.org/10.1007/s00228-016-2090-5.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Roozbeh N, Kashef R, Ghazanfarpour M, Kargarfard L, Darvish L, Khadivzadeh T et al. Overview of the Effect of Herbal Medicines and Isoflavones on the Treatment of Cognitive Function. J Menopausal Med. 2018;24(2):113–118. https://doi.org/10.6118/jmm.2018.24.2.113.</mixed-citation><mixed-citation xml:lang="en">Roozbeh N, Kashef R, Ghazanfarpour M, Kargarfard L, Darvish L, Khadivzadeh T et al. Overview of the Effect of Herbal Medicines and Isoflavones on the Treatment of Cognitive Function. J Menopausal Med. 2018;24(2):113–118. https://doi.org/10.6118/jmm.2018.24.2.113.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wong WW, Lewis RD, Steinberg FM, Murray MJ, Cramer MA, Amato P et al. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr. 2009;90(5):1433–1439. https://doi.org/10.3945/ajcn.2009.28001.</mixed-citation><mixed-citation xml:lang="en">Wong WW, Lewis RD, Steinberg FM, Murray MJ, Cramer MA, Amato P et al. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr. 2009;90(5):1433–1439. https://doi.org/10.3945/ajcn.2009.28001.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.</mixed-citation><mixed-citation xml:lang="en">Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98(1):9–14. https://doi.org/10.1038/sj.bjc.6604145.</mixed-citation><mixed-citation xml:lang="en">Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98(1):9–14. https://doi.org/10.1038/sj.bjc.6604145.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2011;125(2):315–323. https://doi.org/10.1007/s10549-010-1270-8.</mixed-citation><mixed-citation xml:lang="en">Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2011;125(2):315–323. https://doi.org/10.1007/s10549-010-1270-8.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang GQ, Chen JL, Liu Q, Zhang Y, Zeng H, Zhao Y. Soy Intake Is Associated With Lower Endometrial Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94(50):e2281. https://doi.org/10.1097/MD.0000000000002281.</mixed-citation><mixed-citation xml:lang="en">Zhang GQ, Chen JL, Liu Q, Zhang Y, Zeng H, Zhao Y. Soy Intake Is Associated With Lower Endometrial Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94(50):e2281. https://doi.org/10.1097/MD.0000000000002281.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Yuan F, Gao J, Shan B, Ren Y, Wang H, Gao Y. Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials. Oncotarget. 2016;7(14):17369–17379. https://doi.org/10.18632/oncotarget.7959.</mixed-citation><mixed-citation xml:lang="en">Liu J, Yuan F, Gao J, Shan B, Ren Y, Wang H, Gao Y. Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials. Oncotarget. 2016;7(14):17369–17379. https://doi.org/10.18632/oncotarget.7959.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Dong JY, Wang P, He K, Qin LQ. Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials. Menopause. 2011;18(11):1256–1262. https://doi.org/10.1097/gme.0b013e31821bfa24.</mixed-citation><mixed-citation xml:lang="en">Dong JY, Wang P, He K, Qin LQ. Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials. Menopause. 2011;18(11):1256–1262. https://doi.org/10.1097/gme.0b013e31821bfa24.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Delman DM, Fabian CJ, Kimler BF, Yeh H, Petroff BK. Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development. Nutr Cancer. 2015;67(5):857–864. https://doi.org/10.1080/01635581.2015.1042549.</mixed-citation><mixed-citation xml:lang="en">Delman DM, Fabian CJ, Kimler BF, Yeh H, Petroff BK. Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development. Nutr Cancer. 2015;67(5):857–864. https://doi.org/10.1080/01635581.2015.1042549.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Musial C, Kuban-Jankowska A, Gorska-Ponikowska M. Beneficial Properties of Green Tea Catechins. Int J Mol Sci. 2020;21(5):1744. https://doi.org/10.3390/ijms21051744.</mixed-citation><mixed-citation xml:lang="en">Musial C, Kuban-Jankowska A, Gorska-Ponikowska M. Beneficial Properties of Green Tea Catechins. Int J Mol Sci. 2020;21(5):1744. https://doi.org/10.3390/ijms21051744.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Tadayon M, Movahedi S, Abedi P, Syahpoosh A. Impact of green tea extract on serum lipid of postmenopausal women: A randomized controlled trial. J Tradit Complement Med. 2017;8(3):391–395. https://doi.org/10.1016/j.jtcme.2017.07.005.</mixed-citation><mixed-citation xml:lang="en">Tadayon M, Movahedi S, Abedi P, Syahpoosh A. Impact of green tea extract on serum lipid of postmenopausal women: A randomized controlled trial. J Tradit Complement Med. 2017;8(3):391–395. https://doi.org/10.1016/j.jtcme.2017.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Rondanelli M, Gasparri C, Perna S, Petrangolini G, Allegrini P, Fazia T et al. A 60-Day Green Tea Extract Supplementation Counteracts the Dysfunction of Adipose Tissue in Overweight Post-Menopausal and Class I Obese Women. Nutrients. 2022;14(24):5209. https://doi.org/10.3390/nu14245209.</mixed-citation><mixed-citation xml:lang="en">Rondanelli M, Gasparri C, Perna S, Petrangolini G, Allegrini P, Fazia T et al. A 60-Day Green Tea Extract Supplementation Counteracts the Dysfunction of Adipose Tissue in Overweight Post-Menopausal and Class I Obese Women. Nutrients. 2022;14(24):5209. https://doi.org/10.3390/nu14245209.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int. 2005;16(12):2039–2045. https://doi.org/10.1007/s00198-005-1995-0.</mixed-citation><mixed-citation xml:lang="en">Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int. 2005;16(12):2039–2045. https://doi.org/10.1007/s00198-005-1995-0.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lin RW, Chen CH, Wang YH, Ho ML, Hung SH, Chen IS, Wang GJ. (–)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB. Biochem Biophys Res Commun. 2009;379(4):1033–1037. https://doi.org/10.1016/j.bbrc.2009.01.007.</mixed-citation><mixed-citation xml:lang="en">Lin RW, Chen CH, Wang YH, Ho ML, Hung SH, Chen IS, Wang GJ. (–)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB. Biochem Biophys Res Commun. 2009;379(4):1033–1037. https://doi.org/10.1016/j.bbrc.2009.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Shen CL, Yeh JK, Cao JJ, Wang JS. Green tea and bone metabolism. Nutr Res. 2009;29(7):437–456. https://doi.org/10.1016/j.nutres.2009.06.008.</mixed-citation><mixed-citation xml:lang="en">Shen CL, Yeh JK, Cao JJ, Wang JS. Green tea and bone metabolism. Nutr Res. 2009;29(7):437–456. https://doi.org/10.1016/j.nutres.2009.06.008.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ших ЕВ, Махова АА. Эндемичность территории по дефициту микронутриентов как критерий формирования состава базового витаминно-минерального комплекса для периконцепционального периода. Акушерство и гинекология. 2018;(10):25–32. https://doi.org/10.18565/aig.2018.10.25-32.</mixed-citation><mixed-citation xml:lang="en">Shikh EV, Makhova AA. The endemicity of an area in terms of micronutrient deficiencies as a criterion for compounding a basic vitamin-mineral complex for the periconceptional period. Akusherstvo i Ginekologiya (Russian Federation). 2018;(10):25–32. (In Russ.) https://doi.org/10.18565/aig.2018.10.25-32.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hyvärinen M, Juppi HK, Taskinen S, Karppinen JE, Karvinen S, Tammelin TH et al. Metabolic health, menopause, and physical activity-a 4-year follow-up study. Int J Obes (Lond). 2022;46(3):544–554. https://doi.org/10.1038/s41366-021-01022-x.</mixed-citation><mixed-citation xml:lang="en">Hyvärinen M, Juppi HK, Taskinen S, Karppinen JE, Karvinen S, Tammelin TH et al. Metabolic health, menopause, and physical activity-a 4-year follow-up study. Int J Obes (Lond). 2022;46(3):544–554. https://doi.org/10.1038/s41366-021-01022-x.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Guthrie JR, Dennerstein L, Taffe JR, Ebeling PR, Randolph JF, Burger HG, Wark JD. Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril. 2003;79(6):1335–1340. https://doi.org/10.1016/s0015-0282(03)00361-3.</mixed-citation><mixed-citation xml:lang="en">Guthrie JR, Dennerstein L, Taffe JR, Ebeling PR, Randolph JF, Burger HG, Wark JD. Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril. 2003;79(6):1335–1340. https://doi.org/10.1016/s0015-0282(03)00361-3.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Millen BE, Pencina MJ, Kimokoti RW, Zhu L, Meigs JB, Ordovas JM, D'Agostino RB. Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr. 2006;84(2):434–441. https://doi.org/10.1093/ajcn/84.1.434.</mixed-citation><mixed-citation xml:lang="en">Millen BE, Pencina MJ, Kimokoti RW, Zhu L, Meigs JB, Ordovas JM, D'Agostino RB. Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr. 2006;84(2):434–441. https://doi.org/10.1093/ajcn/84.1.434.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Moore-Schiltz L, Albert JM, Singer ME, Swain J, Nock NL. Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001-2010 data. Br J Nutr. 2015;114(6):924–935. https://doi.org/10.1017/S0007114515002482.</mixed-citation><mixed-citation xml:lang="en">Moore-Schiltz L, Albert JM, Singer ME, Swain J, Nock NL. Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001-2010 data. Br J Nutr. 2015;114(6):924–935. https://doi.org/10.1017/S0007114515002482.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28(6):1438–1444. https://doi.org/10.2337/diacare.28.6.1438.</mixed-citation><mixed-citation xml:lang="en">Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28(6):1438–1444. https://doi.org/10.2337/diacare.28.6.1438.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur J Clin Nutr. 2014;68(4):510–516. https://doi.org/10.1038/ejcn.2014.7.</mixed-citation><mixed-citation xml:lang="en">Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur J Clin Nutr. 2014;68(4):510–516. https://doi.org/10.1038/ejcn.2014.7.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279(5):359–364. https://doi.org/10.1001/jama.279.5.359.</mixed-citation><mixed-citation xml:lang="en">Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279(5):359–364. https://doi.org/10.1001/jama.279.5.359.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ishihara J, Iso H, Inoue M, Iwasaki M, Okada K, Kita Y et al. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr. 2008;27(1):127–136. https://doi.org/10.1080/07315724.2008.10719684.</mixed-citation><mixed-citation xml:lang="en">Ishihara J, Iso H, Inoue M, Iwasaki M, Okada K, Kita Y et al. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr. 2008;27(1):127–136. https://doi.org/10.1080/07315724.2008.10719684.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sacharow SJ, Picker JD, Levy HL. Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds.). GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2023. Available at: https://pubmed.ncbi.nlm.nih.gov/20301697/.</mixed-citation><mixed-citation xml:lang="en">Sacharow SJ, Picker JD, Levy HL. Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds.). GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2023. Available at: https://pubmed.ncbi.nlm.nih.gov/20301697/.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Ших ЕВ, Махова АА. Ключевые микронутриенты репродуктивного периода – фолаты и докозагексаеновая омега-3 полиненасыщенная жирная кислота – в профилактике перинатальной депрессии. Вопросы гинекологии, акушерства и перинатологии. 2020;19(2):78–84. https://doi.org/10.20953/1726-1678-2020-2-78-84.</mixed-citation><mixed-citation xml:lang="en">Shikh EV, Makhova AA. Key micronutrients of the reproductive period – folates and docosahexaenoic omega-3 polyunsaturated acid – in prevention of perinatal depression. Gynecology, Obstetrics and Perinatology. 2020;19(2):78–84. (In Russ.) https://doi.org/10.20953/1726-1678-2020-2-78-84.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Дикевич ЕА, Овинникова ТЕ. Терапия депрессивных расстройств, связанных с перименопаузой. РМЖ. 2008;(12):1720–1724. Режим доступа: https://www.rmj.ru/articles/psikhiatriya/Terapiya_depressivnyh_rasstroystv_svyazannyh_s_perimenopauzoy/.</mixed-citation><mixed-citation xml:lang="en">Dikevich EA, Ovinnikova TE. Treatment of depressive disorders associated with perimenopause. RMJ. 2008;(12):1720–1724. (In Russ.) Available at: https://www.rmj.ru/articles/psikhiatriya/Terapiya_depressivnyh_rasstroystv_svyazannyh_s_perimenopauzoy/.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Cicero AF, Minervino A. Combined action of SAMe, Folate, and Vitamin B12 in the treatment of mood disorders: a review. Eur Rev Med Pharmacol Sci. 2022;26(7):2443–2459. https://doi.org/10.26355/eurrev_202204_28479.</mixed-citation><mixed-citation xml:lang="en">Cicero AF, Minervino A. Combined action of SAMe, Folate, and Vitamin B12 in the treatment of mood disorders: a review. Eur Rev Med Pharmacol Sci. 2022;26(7):2443–2459. https://doi.org/10.26355/eurrev_202204_28479.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hayhoe RP, Lentjes MA, Luben RN, Khaw KT, Welch AA. Dietary magnesium and potassium intakes and circulating magnesium are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the EPIC-Norfolk cohort study. Am J Clin Nutr. 2015;102(2):376–384. https://doi.org/10.3945/ajcn.114.102723.</mixed-citation><mixed-citation xml:lang="en">Hayhoe RP, Lentjes MA, Luben RN, Khaw KT, Welch AA. Dietary magnesium and potassium intakes and circulating magnesium are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the EPIC-Norfolk cohort study. Am J Clin Nutr. 2015;102(2):376–384. https://doi.org/10.3945/ajcn.114.102723.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018;118(3):181–189. https://doi.org/10.7556/jaoa.2018.037.</mixed-citation><mixed-citation xml:lang="en">Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018;118(3):181–189. https://doi.org/10.7556/jaoa.2018.037.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Farsinejad-Marj M, Saneei P, Esmaillzadeh A. Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis. Osteoporos Int. 2016;27(4):1389–1399. https://doi.org/10.1007/s00198-015-3400-y.</mixed-citation><mixed-citation xml:lang="en">Farsinejad-Marj M, Saneei P, Esmaillzadeh A. Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis. Osteoporos Int. 2016;27(4):1389–1399. https://doi.org/10.1007/s00198-015-3400-y.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
